Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sandoz Gets New Leader: Is Restructuring Next For Novartis’ Generics Unit?

Executive Summary

Novartis is focusing on operational efficiencies in its Sandoz generics business to address a difficult pricing environment in the U.S

You may also be interested in...



Novartis Seeks To Be Generics “Powerhouse” With Eon, Hexal Acquisitions

Novartis expects the addition of Eon Labs and Hexal AG to its Sandoz division to create a generic drug "powerhouse" that will play a major role in the emerging "authorized" generics and follow-on biologics markets

Novartis Seeks To Be Generics “Powerhouse” With Eon, Hexal Acquisitions

Novartis expects the addition of Eon Labs and Hexal AG to its Sandoz division to create a generic drug "powerhouse" that will play a major role in the emerging "authorized" generics and follow-on biologics markets

Generic Industry Faces Downturn, Sandoz Says; MMA Changes Hurt

The generic industry is facing a "downturn" in the market for products with low barriers to entry, Sandoz CEO Andreas Rummelt said Jan. 20

Related Content

UsernamePublicRestriction

Register

PS044880

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel